Comorbid infections in rheumatic diseases (according to FSBI RIR named after V.A. Nasonova)

Comorbid infections in rheumatic diseases (according to FSBI RIR named after V.A. Nasonova)

Aim. Study of spectrum, frequency and risk factors of comorbid infections in rheumatic diseases (RD) in the stationary contingent of patients hospitalized in the FSBI RIR named after V.A. Nasonova within 1 year.Patients and methods. The study included 245 patients with RD: 122 patients suffered from...

Full description

Bibliographic Details
Main Authors:	D. V. Bukhanova, B. S. Belov, G. M. Tarasova, S. K. Soloviev, L. P. Ananyeva, T. V. Popkova, A. V. Gordeev, Yu. V. Muravyov, S. I. Glukhova
Format:	Article
Language:	Russian
Published:	Remedium Group LLC 2019-06-01
Series:	Медицинский совет
Subjects:	infections rheumatoid arthritis systemic lupus erythematosus systemic scleroderma pneumonia
Online Access:	https://www.med-sovet.pro/jour/article/view/3039

Similar Items

The uses and misuses of multiplex autoantibody assays in systemic autoimmune rheumatic diseases
by: Minoru eSatoh, et al.
Published: (2015-04-01)

Spectrum of central nervous system involvement in rheumatic diseases: pictorial essay
by: Renata Mendes Vieira, et al.
Published: (2018-07-01)

Shrinking lung syndrome in systemic lupus erythematosus-scleroderma overlap
by: Vivek S Guleria, et al.
Published: (2014-01-01)

VIRAL HEPATITIS B AND C AS COMORBIDITY IN RHEUMATIC DISEASES: ANALYSIS OF THE DATA OF THE V.A. NASONOVA RESEARCH INSTITUTE OF RHEUMATOLOGY CLINIC OVER 4 YEARS
by: A. E. Karateev, et al.
Published: (2016-07-01)

Connective Tissue Diseases: Challenges of management among Nigerians
by: Adelowo OO
Published: (2016-12-01)

Herpes zoster virus infection and rheumatic diseases: Current state of the problem
by: D. V. Bukhanova, et al.
Published: (2016-09-01)

STUDIES DEVOTED TO ANTIPHOSPHOLIPID SYNDROME AT THE V.A. NASONOVA RESEARCH INSTITUTE OF RHEUMATOLOGY: MAIN ACHIEVEMENTS (ON THE OCCASION OF THE 40th ANNIVERSARY OF THE DISSERTATION BOARD)
by: T. M. Reshetnyak
Published: (2017-01-01)

Intravenous iloprost in the combination therapy of vascular disorders in patients with systemic connective tissue diseases
by: Aleksandr Vitalyevich Volkov, et al.
Published: (2013-06-01)

Pulmonary hypertension in systemic sclerosis and systemic lupus erythematosus
by: S.R. Johnson, et al.
Published: (2011-12-01)

Comorbid infections in patients with systemic lupus erythematosus: State-of-the-art
by: B. S. Belov, et al.
Published: (2016-10-01)

Brachial artery responsiveness in patients with systemic lupus erythematosus and scleroderma systematica
by: Aleksey Alekseevich Vinogradov, et al.
Published: (2010-03-01)

CURRENT VIEWS ON THE HETEROGENEITY OF RENAL INVOLVEMENTS IN PATIENTS WITH SYSTEMIC SCLEROSIS
by: A. V. Gordeev, et al.
Published: (2015-09-01)

Vaccination in rheumatology: Evolution of views on the problem
by: B S Belov, et al.
Published: (2017-05-01)

Systemic sclerosis and pregnancy outcomes: a retrospective study from a single center
by: Baños, N., et al.
Published: (2022)

According to the 2019 updated European League Against Rheumatism (EULAR) recommendations for the treatment of systemic lupus erythematosus: debatable issues and comments
by: T. V. Popkova, et al.
Published: (2019-11-01)

THE MAIN RESULTS OF COOPERATION BETWEEN THE V.A. NASONOVA RESEARCH INSTITUTE OF RHEUMATOLOGY AND RESEARCH CENTERS OF EUROPE WITHIN THE EUSTAR (EULAR SCLERODERMA TRIALS AND RESEARCH GROUP) IN SYSTEMIC SCLEROSIS
by: L. P. Ananyeva, et al.
Published: (2014-12-01)

KONSUPREN IN THETHERAPY OF RHEUMATIC DISEASES
by: Z S Alekberova, et al.
Published: (2001-04-01)

Problems of early diagnosis of systemic lupus erythematosus during the COVID-19 pandemic
by: E. L. Nasonov, et al.
Published: (2021-05-01)

Dermatological findings in common rheumatologic diseases in children
by: Melike Kibar Ozturk, et al.
Published: (2019-06-01)

Lymphatic Function in Autoimmune Diseases
by: Noa Schwartz, et al.
Published: (2019-03-01)

Effect of rituximab on heart involvement in systemic sclerosis
by: L. A. Garzanova, et al.
Published: (2019-01-01)

Positivity for antiribonucleoprotein antibodies in rheumatic diseases: focus on scleroderma systematica
by: R. U. Shayakhmetova, et al.
Published: (2018-01-01)

Bone mineral density and fracture risk in patients with rheumatic diseases
by: O. V. Dobrovolskaya, et al.
Published: (2020-07-01)

Type I Interferon in Human Autoimmunity
by: Timothy B. Niewold
Published: (2014-06-01)

INVESTIGATION OF IMMUNOGENICITY AND SAFETY OF 23-VALENT POLYSACCHARIDE PNEUMOCOCCAL VACCINE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
by: G. M. Tarasova, et al.
Published: (2018-09-01)

Bosentan: A considerable increase in the survival of patients with pulmonary hypertension associated with systemic rheumatic diseases
by: A V Volkov, et al.
Published: (2014-05-01)

UNILATERAL LUNG INJURY IN SCLERODERMA SYSTEMATICA: A CASE REPORT
by: R. T. Alekperov, et al.
Published: (2014-09-01)

PROCALCITONIN TESTING IN RHEUMATOLOGY
by: D. V. Bukhanova, et al.
Published: (2017-12-01)

Contribution of academician V.A. NAsonova to the development of russian rheumatology
by: O M Folomeeva
Published: (2008-06-01)

Arterial hypertension in patients with systemic connective tissue diseases and hemorrhagic vasculitis
by: Nataliya Petrovna Shilkina, et al.
Published: (2010-05-01)

Systemic Sclerosis Sine Scleroderma Manifested with Gastrointestinal Bleeding, Antiphospholipid Syndrome and Positive Anti-RNA Polymerase III Antibody: Case Report and Literature Review
by: Alghamdi M, et al.
Published: (2020-08-01)

Use of the international systemic scleroderma activity index
by: Maya Nikolayevna Starovoitova, et al.
Published: (2013-03-01)

Esophageal involvement in progressive systemic sclerosis
by: Stephen A. Geller, et al.
Published: (2013-10-01)

The state of the digestive system in children with systemic connective tissue diseases
by: I. D. Chyzhevskaya, et al.
Published: (2020-03-01)

Management of patients with systemic lupus erythematosus in real clinical practice
by: E. A. Aseeva, et al.
Published: (2019-05-01)

POSSIBILITIES OF USING LEFLUNOMIDE IN RHEUMATIC DISEASES
by: E V Igolkina, et al.
Published: (2011-03-01)

POSSIBILITIES OF USING LEFLUNOMIDE IN RHEUMATIC DISEASES
by: E V Igolkina, et al.
Published: (2011-03-01)

EFFECT OF AT ORVASTATIN ON THE TIME COURSE OF CHANGESIN INFLAMMATORY MARKERS IN SYSTEMIC SCLERODERMA
by: R T Alekperov, et al.
Published: (2011-04-01)

Evaluation of clinical symptoms of patients with scleroderma according to the onset time1
by: Khalvat A, et al.
Published: (2000-07-01)

Intralesional overlap syndrome: Sclerodermic lupus panniculitis and sclerodermic discoid lupus erythematosus
by: Ziv Schwartz, MHA, et al.
Published: (2020-03-01)